Neon Therapeutics Inc (NTGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -79,776 | -76,934 | -47,536 | -27,433 |
| Depreciation Amortization | 1,649 | 1,454 | 1,110 | 411 |
| Accounts payable and accrued liabilities | -2,311 | 1,951 | -942 | 1,029 |
| Other Working Capital | -3,850 | 5,798 | 2,084 | 1,457 |
| Other Operating Activity | 10,876 | 4,303 | 4,003 | 379 |
| Operating Cash Flow | $-73,412 | $-63,428 | $-41,281 | $-24,157 |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -1,084 | -3,222 | -3,242 | -2,357 |
| Purchase Of Investment | 0 | -72,939 | -33,979 | N/A |
| Sale Of Investment | 50,681 | 43,550 | 12,300 | N/A |
| Investing Cash Flow | $49,597 | $-32,611 | $-24,921 | $-2,357 |
| Cash Flows From Financing Activities | ||||
| Common Stock Issued | 512 | 93,404 | 55 | N/A |
| Common Stock Repurchased | -2 | -1 | -4 | N/A |
| Other Financing Activity | 0 | -3,065 | 35,858 | 111,120 |
| Financing Cash Flow | $510 | $90,338 | $35,909 | $111,120 |
| Beginning Cash Position | 53,156 | 58,857 | 89,150 | 4,544 |
| End Cash Position | 29,851 | 53,156 | 58,857 | 89,150 |
| Net Cash Flow | $-23,305 | $-5,701 | $-30,293 | $84,606 |
| Free Cash Flow | ||||
| Operating Cash Flow | -73,412 | -63,428 | -41,281 | -24,157 |
| Capital Expenditure | -1,084 | -3,222 | -3,242 | -2,396 |
| Free Cash Flow | -74,496 | -66,650 | -44,523 | -26,553 |